TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2,298 Cr | ₹-2,780 Cr | ₹77 Cr | ₹-1,781 Cr | ₹-1,651 Cr |
What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-2,298 Cr |
| Mar2024 | ₹-2,780 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹-1,781 Cr |
| Mar2021 | ₹-1,651 Cr |
How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2,298 Cr | Negative | |
| Mar2024 | ₹-2,780 Cr | Negative | |
| Mar2023 | ₹77 Cr | Positive | |
| Mar2022 | ₹-1,781 Cr | Negative | |
| Mar2021 | ₹-1,651 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹144,420.7 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
| MANKIND PHARMA | ₹82,555.3 Cr | -4.4% | -3.6% | -7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.1% |
1.4% |
37.6% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses